Bajić Dejana, Todorović Nemanja, Popović Mladena Lalić, Plazačić Milica, Mihajlović Andrea
Department of Biochemistry, Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia.
Department of Pharmacy, Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia.
Innate Immun. 2025 Jan-Dec;31:17534259251362023. doi: 10.1177/17534259251362023. Epub 2025 Jul 27.
The gut microbiome plays a crucial role in shaping immune responses, and its connection to immunity has never been more relevant than in the COVID-19 era. The interaction between gut microbes and the immune system, known as microbiome-immunity crosstalk, influences both how the body responds to infections and how well it recovers. COVID-19, whether in its acute phase or lingering as long COVID, has been linked to disturbances in the gut microbiome. During infection, many patients experience dysbiosis-an imbalance in gut bacteria-that can contribute to immune dysfunction and excessive inflammation. This imbalance may not only worsen the severity of the disease but also prolong recovery, leading to persistent symptoms like fatigue, brain fog, and digestive issues. Long COVID, in particular, has been associated with ongoing immune dysregulation, where the body's defense system remains in a state of heightened activation, causing chronic inflammation. Given the strong link between gut health and immunity, there is growing interest in strategies to restore microbial balance. Synbiotics-combinations of probiotics (beneficial bacteria) and prebiotics (nutrients that support them)-are being explored as a potential therapeutic approach. By replenishing beneficial gut microbes, synbiotics may help regulate immune responses, reduce inflammation, and support overall recovery from COVID-19. Emerging research suggests that improving gut health could enhance the body's ability to fight infections and recover more efficiently. As we continue to understand the long-term impact of COVID-19, focusing on the gut microbiome offers a promising path forward. Supporting a balanced and diverse microbiome through diet, lifestyle, and targeted interventions like synbiotics may provide a natural way to strengthen immunity and improve health outcomes in both acute and long COVID cases.
肠道微生物群落在塑造免疫反应中起着至关重要的作用,其与免疫的联系在新冠疫情时代比以往任何时候都更加紧密。肠道微生物与免疫系统之间的相互作用,即微生物群-免疫串扰,既影响身体对感染的反应方式,也影响身体恢复的情况。新冠病毒感染,无论是急性期还是发展为长期新冠,都与肠道微生物群的紊乱有关。在感染期间,许多患者会出现肠道细菌失衡的失调现象,这可能导致免疫功能障碍和过度炎症。这种失衡不仅可能使疾病的严重程度恶化,还会延长恢复时间,导致疲劳、脑雾和消化问题等持续症状。特别是长期新冠,一直与持续的免疫失调有关,即身体的防御系统一直处于高度激活状态,引发慢性炎症。鉴于肠道健康与免疫之间的紧密联系,人们对恢复微生物平衡的策略越来越感兴趣。合生元,即益生菌(有益细菌)和益生元(支持它们的营养素)的组合,正被探索作为一种潜在的治疗方法。通过补充有益的肠道微生物,合生元可能有助于调节免疫反应、减轻炎症,并支持从新冠病毒感染中全面恢复。新兴研究表明,改善肠道健康可以增强身体对抗感染的能力,并更有效地恢复。随着我们继续了解新冠病毒感染的长期影响,关注肠道微生物群提供了一条充满希望的前进道路。通过饮食、生活方式以及合生元等有针对性的干预措施来支持平衡且多样的微生物群,可能为增强免疫力以及改善急性和长期新冠病例的健康状况提供一种自然的方法。
Cochrane Database Syst Rev. 2022-9-20
Cochrane Database Syst Rev. 2025-7-10
Cochrane Database Syst Rev. 2023-10-23
Cochrane Database Syst Rev. 2023-2-17
Therap Adv Gastroenterol. 2025-6-16
ACS Infect Dis. 2025-7-11
Diabetes Obes Metab. 2025-5-15
BMJ Glob Health. 2024-10-21
Inflammopharmacology. 2024-12
Cell. 2024-10-3
Gut. 2024-10-7
Precis Clin Med. 2024-7-18